Skip to content

Nasdaq · CIK 0001077183

NEO NEOGENOMICS INC

Insider trading from SEC Form 4. Last filing 38 d ago. Close $16.35 on Oct 9, 2026, +127% from the 52-week low and -18% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company

Price and insider trades, last year

NEOOct 9, 2026 · close 16.35

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at NEOGENOMICS INC, scored.

ScoreSideInsiderValueSharesHoldings changePrice contextFiled
9Weaksell10b5-1Alicia C Olivo
General Counsel
$79k5,175-12%-

Congressional trades

2 trades in NEO disclosed by members of Congress under the STOCK Act. All congressional trades.

MemberTypeAssetAmountTradedFiled
Gilbert Ray Cisneros, Jr.
House · D-CA
PurchaseNEO
NeoGenomics, Inc. - Common Stock
$1,001 to $15kAug 7, 2026
34 days after the trade
Gilbert Ray Cisneros, Jr.
House · D-CA
PurchaseNEO
NeoGenomics, Inc. - Common Stock
$1,001 to $15kMay 7, 2025
30 days after the trade

Transactions

The last 24 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 1, 2026Alicia C Olivo
EVP, GC & Business Development
FTax withholding
Common Stock
-2,692$0.00$090,87538 d ago
Feb 23, 2025Melody Harris
Chf Ops Off, Pres, Informatics
MOption exercise
Common Stock
+8,443$0.00$0111,811Feb 25, 2025
Feb 23, 2025Melody Harris
Chf Ops Off, Pres, Informatics
FTax withholding
Common Stock
-2,056$0.00$0109,755Feb 25, 2025
Feb 21, 2025Greg D Aunan
Chief Accounting Officer
AGrant or award
Stock Option (Right to Buy)derivative
+31,163$0.00$031,163Feb 25, 2025
Feb 21, 2025Greg D Aunan
Chief Accounting Officer
AGrant or award
Restricted Stock Unitderivative
+18,971$0.00$018,971Feb 25, 2025
Feb 21, 2025Melody Harris
Chf Ops Off, Pres, Informatics
AGrant or award
Stock Option (Right to Buy)derivative
+143,266$0.00$0143,266Feb 25, 2025
Feb 21, 2025Melody Harris
Chf Ops Off, Pres, Informatics
AGrant or award
Restricted Stock Unitderivative
+84,317$0.00$084,317Feb 25, 2025
Feb 23, 2025Melody Harris
Chf Ops Off, Pres, Informatics
MOption exercise
Restricted Stock Unitderivative
-8,443$0.00$016,886Feb 25, 2025
Jan 14, 2025Melody Harris
Chf Ops Off, Pres, Informatics
AGrant or award
Restricted Stock Unitderivative
+59,382$0.00$059,382Jan 16, 2025
Jan 1, 2025Melody Harris
Chf Ops Off, Pres, Informatics
FTax withholding
Common Stock
-7,070$0.00$0102,820Jan 3, 2025
Dec 7, 2024Jeffrey Scott Sherman
Chief Financial Officer
FTax withholding
Common Stock
-11,746$0.00$0123,754Dec 10, 2024
May 11, 2024Alicia C Olivo
General Counsel
MOption exercise
Common Stock
+6,502$0.00$040,998Dec 4, 2024
May 11, 2024Christopher M Smith
Chief Executive Officer
MOption exercise
Common Stock
+48,063$0.00$0650,282Dec 4, 2024
May 11, 2024Jeffrey Scott Sherman
Chief Financial Officer
MOption exercise
Common Stock
+13,005$0.00$0138,667Dec 4, 2024
May 11, 2024Alicia C Olivo
General Counsel
FTax withholding
Common Stock
-1,584$14.86$24k39,414Dec 4, 2024
May 11, 2024Christopher M Smith
Chief Executive Officer
FTax withholding
Common Stock
-18,913$14.86$281k631,369Dec 4, 2024
May 11, 2024Jeffrey Scott Sherman
Chief Financial Officer
FTax withholding
Common Stock
-3,167$14.86$47k135,500Dec 4, 2024
May 11, 2024Alicia C Olivo
General Counsel
MOption exercise
Restricted Stock Unitderivative
-6,502$0.00$013,006Dec 4, 2024
May 11, 2024Jeffrey Scott Sherman
Chief Financial Officer
MOption exercise
Restricted Stock Unitderivative
-13,005$0.00$026,011Dec 4, 2024
May 11, 2024Christopher M Smith
Chief Executive Officer
MOption exercise
Restricted Stock Unitderivative
-48,063$0.00$096,127Dec 4, 2024
Dec 1, 2024Warren Stone
Chief Commerical Officer
FTax withholding
Common Stock
-6,224$0.00$084,822Dec 3, 2024
Nov 15, 2024Alicia C Olivo
General Counsel
SOpen-market sale
Common Stock10b5-1
-5,175$15.36$79k37,129Nov 19, 2024
Nov 1, 2024Felicia Williams
director
AGrant or award
Stock Option (Right to Buy)derivative
+5,430$0.00$05,430Nov 5, 2024
Nov 1, 2024Felicia Williams
director
AGrant or award
Restricted Stock Unitderivative
+7,160$0.00$07,160Nov 5, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

NEO insider trading: NEOGENOMICS INC | InsiderTell